MJNA (Medical Marijuana) EBIT: $-135.18 Mil (TTM As of Dec. 2017)


What is Medical Marijuana EBIT?

Medical Marijuana MJNA +100.00% EBIT is $-135.18 Mil as of Dec. 2017.

Medical Marijuana's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2017 was $-135.18 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2017 was $-135.18 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medical Marijuana's annualized ROC % for the quarter that ended in Dec. 2017 was -1.43%. Medical Marijuana's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2017 was -3,620.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medical Marijuana's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2017 was -5,510.80%.


Medical Marijuana  (OTCPK:MJNA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medical Marijuana's annualized ROC % for the quarter that ended in Dec. 2017 is calculated as:

ROC % (Q: Dec. 2017 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2016 ) + Invested Capital (Q: Dec. 2017 ))/ count )
=-4.736 * ( 1 - 0% )/( (391.422 + 271.835)/ 2 )
=-4.736/331.6285
=-1.43 %

where

Note: The Operating Income data used here is one times the annual (Dec. 2017) data.

2. Joel Greenblatt's definition of Return on Capital:

Medical Marijuana's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2017 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2017 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2016  Q: Dec. 2017
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-135.18/( ( (0.925 + max(2.844, 0)) + (0.398 + max(3.3, 0)) )/ 2 )
=-135.18/( ( 3.769 + 3.698 )/ 2 )
=-135.18/3.7335
=-3,620.73 %

where Working Capital is:

Working Capital(Q: Dec. 2016 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.198 + 3.411 + 0.256) - (1.021 + 0 + 4.4408920985006E-16)
=2.844

Working Capital(Q: Dec. 2017 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.106 + 3.856 + 0.047000000000001) - (0.709 + 0 + 4.4408920985006E-16)
=3.3

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2017) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medical Marijuana's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2017 )
=-135.18/2.453
=-5,510.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medical Marijuana EBIT Related Terms


Medical Marijuana EBIT Historical Data

* Premium members only.

The historical data trend for Medical Marijuana's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Marijuana EBIT Chart

Medical Marijuana Annual Data
Trend Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EBIT
Get a 7-Day Free Trial -1.00 -3.54 -100.19 -15.24 -135.18

Medical Marijuana Semi-Annual Data
Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EBIT Get a 7-Day Free Trial -1.00 -3.54 -100.19 -15.24 -135.18

MJNA vs UPC, ERBB, KAYS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Marijuana's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Marijuana EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Marijuana's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medical Marijuana's EV-to-EBIT falls into.



Medical Marijuana EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2017 was $-135.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-135.18 Mil mean?
Medical Marijuana (MJNA) has a EBIT of $-135.18 Mil as of Dec. 2017. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medical Marijuana.
Is Medical Marijuana's EBIT too high?
Medical Marijuana's current EBIT is $-135.18 Mil.
How does Medical Marijuana's EBIT compare to UPC and ERBB?
Medical Marijuana's EBIT of $-135.18 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medical Marijuana. Medical Marijuana's current EBIT is $-135.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Marijuana stock overvalued right now?
Medical Marijuana (MJNA) has a current EBIT of $-135.18 Mil. The current EBIT is $-135.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Medical Marijuana (MJNA), the current EBIT is $-135.18 Mil as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medical Marijuana Business Description

Address 2384 La Mirada Drive, Vista, CA, USA, 92081
Medical Marijuana Inc is engaged in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol and other products containing CBD-rich hemp oil. The company's products are used by pharmaceutical, nutraceutical, and cosmeceutical industries. Some of its products are CBD Capsules, CBD Tinctures, Vaporizers, and Hemp foods among others. The company operates through Retail and Wholesale division; Direct Sales division; and Manufacturing and Production Division.